Chemical synthetic method of low affinity ligand of oxidized low density lipoprotein receptor CD36
A low-density lipoprotein and chemical synthesis technology is applied in the field of chemical synthesis of oxidized low-density lipoprotein receptor CD36 low-affinity ligands, and can solve the problems of low purity of oxLig-1 and complicated operation procedures.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] The present invention includes chemically synthesizing a small molecule lipid compound of OxLDL, oxLig-1; through structural analysis, it is found that oxLig-1 has a chemical structure completely consistent with that of CD36 low-affinity ligand; oxLig-1 can activate mouse macrophage The scavenger receptor CD36 on the surface of phagocyte J774A.1 activates ERK and JNK, and upregulates the expression of ABCA1. Proceed as follows:
[0044] (1) Chemical synthesis of oxLig-1
[0045] (1) chemical reaction
[0046] First, the catalysts 4-Dimethylaminopyridine (DMAP; 0.125 mM) and N,N'-Dicyclohexylcarbodiimide (DCC; 0.1875 mM) were dissolved in 10 mL of dichloromethane, stirred at room temperature for half an hour, and then azelaic acid (93.1 mg, 0.500 mM ) was also dissolved in it and stirred for another 2 h, and finally 7-ketocholesterol (7-ketocholesterol, 0.125 mM) which was also dissolved in dichloromethane was added dropwise from a constant pressure funnel. The reacta...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com